Table 3

Number of AKs by treatment group (n = 42)

Baseline*End of study*Change
Embedded ImageSEEmbedded ImageSEEmbedded ImageSE
Placebo34.33.826.33.8−8.02.2
Treated34.03.828.03.7−6.02.2
  • *Only the initial number of AKs on the placebo arm was normally distributed.

  • Change variables are normally distributed.